Updating technology appraisal recommendations for COVID-19 medicines: revised approach
Closed for comments This consultation ended on at Request commenting lead permission
Introduction
Following the consultation on the surveillance and update of technology appraisal recommendations for COVID-19 medicines that took place between 6 April and 5 May 2023, NICE has considered the consultation comments. The consultation comments can be found in full in appendix 1 of this document.
This document is structured as follows: 1. What we heard in consultation, 2. New issue – data availability and 3. What we plan to do.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions